GuideHaematology
CMML: Spanish and Düsseldorf prognostic scores
Two classic myelodysplastic syndrome indices applied to chronic myelomonocytic leukaemia.
Updated 3 November 2026
When to use it
Historical context or comparison with older CMML series; for current decisions use CPSS, CPSS-Mol or other CMML-specific indices.
Warning
Historical indices. For current CMML prognosis, specific scores with cytogenetics and mutations are recommended.
What they are
Both scores were designed for myelodysplastic syndromes when CMML was classified among them (FAB). Germing et al. (2004) applied them to 288 CMML patients from the Düsseldorf registry: the Spanish and Düsseldorf scores separated groups with different survival, unlike the IPSS.
Keep reading in the app
- Düsseldorf score (Aul 1992)
- Spanish score (Sanz 1989)
- Spanish CMML cytogenetic risk (Such 2011)
- Limitations
Practical tip
The Düsseldorf score includes LDH, which helps avoid underestimating severity in CMML.
2 more practical tips in the app.
Reference
- Germing U, Kündgen A, Gattermann N. Risk assessment in chronic myelomonocytic leukemia (CMML). Leuk Lymphoma. 2004;45(7):1311-1318.
- Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia. 1992;6(1):52-59.
- Sanz GF, Sanz MA, Vallespí T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 1989;74(1):395-408.
- Such E, Cervera J, Costa D, et al. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica. 2011;96(3):375-383.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
